When the Trump administration ended, one of the issues that it left for the incoming administration was its proposal to withdraw a broad list of medicines and related products from U.S. commitments under the WTO Government Procurement Agreement
On November 27, the U.S. Trade Representative (USTR) complied with President Trump’s directive to take steps to withdraw essential medicines, medical countermeasures and their critical inputs (“Essential Medicines”), identified by the Food and Drug